Aimovig (erenumab-aooe)
Aimovig Autoinjector 2-Pack (140 MG Dose)
NO BOXED WARNING
Dosage & Administration
Dosage & Administration
Coverage Restrictions
Find Restrictions and Step Therapies for Aimovig
drug label
Aimovig Prescribing Information
samples
Request Aimovig Samples
financial assistance
Aimovig Financial Assistance Options
patient education
Aimovig Patient Education
Getting started on Aimovig
To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link
Patient toolkit
people also ask
Aimovig FAQs
Is it safe to use AIMOVIG during pregnancy?There are no adequate data on the developmental risk associated with the use of AIMOVIG in pregnant women. No adverse effects on offspring were observed when pregnant monkeys were administered erenumab-aooe throughout gestation. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2%-4% and 15%-20%, respectively. The estimated rate of major birth defects (2.2%-2.9%) and miscarriage (17%) among deliveries to women with migraine are similar to rates reported in women without migraine. Healthcare providers are advised to consider the potential risks and benefits of AIMOVIG for pregnant women.
Is there any clinical consideration for women with migraine during pregnancy?Published data have suggested that women with migraine may be at increased risk of preeclampsia and gestational hypertension during pregnancy.
What animal data is available for AIMOVIG use during pregnancy?In a study in which female monkeys were administered erenumab-aooe (0 or 50 mg/kg) twice weekly by subcutaneous injection throughout pregnancy (gestation day 20-22 to parturition), no adverse effects on offspring were observed. Serum erenumab-aooe exposures (AUC) in pregnant monkeys were approximately 20 times that in humans at a dose of 140 mg once monthly.
Is it safe to use AIMOVIG while breastfeeding?There are no data on the presence of erenumab-aooe in human milk, the effects on the breastfed infant, or the effects on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for AIMOVIG and any potential adverse effects on the breastfed infant from AIMOVIG or from the underlying maternal condition.
Is AIMOVIG safe for use in pediatric patients?Safety and effectiveness in pediatric patients have not been established.
Is AIMOVIG safe for use in geriatric patients?Clinical studies of AIMOVIG did not include sufficient numbers of patients aged 65 and over to determine whether they respond differently from younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
FAQ Data Source